InvestorsHub Logo
icon url

uksausage

07/14/17 1:54 PM

#111146 RE: art2426 #111145

you could be right.

I am sure there are many combinations of deals being discussed and hypothesized about but no one will put it in ink or blood until the wider FDA clearance is given. Smart insole could be the star product for some one wanting to compete with Dr Scholls.

If they aren't in a shared fulfillment center and hence on web sites of major chains by September though there should be serious discussion about selling.

We are certainly due a Chairman's letter with an update
icon url

Jimzin

07/14/17 4:36 PM

#111156 RE: art2426 #111145

I know it's fun to think big. We all do it to one degree or another. In contrast, AW is a big talker but little doer.

THEY DON'T LEAVE THE AIR CONDITIONED OFFICE EXCEPT TO GO TO INTERNATIONAL PHD TALKATHONS! With OUR money.

Really too bad. The product works great.
icon url

Simpsonly

07/14/17 11:44 PM

#111166 RE: art2426 #111145

Art, if there is not a major player, like the 2 big boys in the drug analgesic space, Pfizer and JnJ, willing to do a revenue sharing, royalty or M&A deal immediately, why not commence 10 simultaneous initiatives? Word will quickly hit the street, be sure of that, such news travels very quickly. Then, if I'm CEO of one of the bigs, do I want to miss out on a patented disruptive technology that shifts my company into leading edge profitable areas? No. Think of the diversification of big tobacco. Both epidemics, smoking and pain drugs, both medical crises, both heavily taxed, but progress must win! Later ......